Dried blood on filter paper collected on the 5th day of life was used t o screen infants for CAH. A radioimmunoassay for 17-OHP without extraction with organic solvents was developed. The cut-off level was initially set a t 100 nmol/l blood based on analyses of stored blood spots from infants who were subsequently found to have CAH.
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NEONATAL SCREENING FOR CONGENITAL ADRENAL HYPEK-PLASIA (CAH) USING 17-HYDROXYPROGESTERONE (17-OHP) ASSAYS OF DRIED BLOOD SPOTS
Dried blood on filter paper collected on the 5th day of life was used t o screen infants for CAH. A radioimmunoassay for 17-OHP without extraction with organic solvents was developed. The cut-off level was initially set a t 100 nmol/l blood based on analyses of stored blood spots from infants who were subsequently found to have CAH.
In a pilot study 22 400 newborns were screened, and 239 (1.1%) were found t o have blood 17-OHP above 100 nmol/l. The majority of these high values (84%) were observed in preterm infants. One case of CAH was detected during this study.
Reassay of blood samples from preterm infants with positive tests after extraction with ether yielded considerably lower 17-OHP levels. A considerable part of the 17-OHP was apparently present as glucuronic acid and monosulphuric acid conjugates.
After introducing cut-off levels related to gestational age and changing t o a more specific antibody the screening has continued and included another 18 800 infants. The recall rate during this period was 0.08%. No further case of CAH has so far been detected. P. Betts*, J. Berry', P.J. Wood* (~n t r o d . by 138 ,.A. ~r e e n g ) Southampton General Hospital. Southampton. England THE INTERPRETATION OF BLOODSPOT 1 7 4 -HYDROXYPROGES-TERONE LEVELS I N TERM AND PRETERM NEONATES Plasma 1 7 d -Hydroxyprogesterone can vary considerably i n t h e f i r s t few days of l i f e . Bloodspot 174-hydroxyprogesterone. plasma c o r t i s o l , plasma sodium and urinary 17M-hydroxyproplesterone, c o r t i s o l , sodium and c r e a t i n i n e l e v e l s were determined i n 24 term and 31 preterm i n f a n t s on t h e t h i r d , eighth and fourteenth day of l i f e . R e t e r m i n f a n t s , whether 'well' o r ' s i c k ' had s i~n i f i c a n t l y r a i s e d bloodspot 17a-hydroyyprogesterone l e v e l s (up t o 158 nmol/l) compared with those found i n term s i c k o r well i n f a n t s (up t o 18.8 nmol/l).
Urinary 17d-hydroxyp r o~e s t e r o n e / c r e a t i n i n e r a t i o s were a l s o higher i n preterm i n f a n t s . Plasma c o r t i s o l r e s u l t s showed similar ranges f o r term and pre-term i n f a n t s , and bloodspot 17d-hydroxypro~esterone/ plasma c o r t i s o l r a t i o s f o r day 3 specimens c o r r e l a t e d with t h e degree of prematurity. These r e s u l t s may be due e i t h e r t o immature enzyme systems i n t h e preterm baby o r t o an excess of r e l a t e d s t e r o i d s cross-reactin6 i n t h e 17d-hydroxypro~esterone assay.
W e propose t h e use of two d i s t i n c t upper limits of normal of 20 nmol/l (term i n f a n t s ) and up t o MOnmol/l (preterm i n f a n t s ) f o r t h e i n t e r p r e t a t i o n of bloodspot 17ol-hydroxypro~esterone l e v e l s a t t h e end of t h e f i r s t week of l i f e .
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M. Dank,= Nielsen*, Lkp. o f c l i n i c a l p h y s i o l q y , G 1 e s t r u p Hospital, 0. Euus*, Medilab., Copnhager,, Denmark, P h i l i p p e Couillin*, U n i t 6 d e recherches d e bicl q i e PrSnatale, P a r i s , France.
The aim o f p r e n a t a l treatment o f CAH is prevention o f v i r i l iz a t i o n o f female f e t u s e s with 21 hydroxylase d e f i c i e n c y (21 CHd e f . ) . ltrs mthers a t r i s k f o r W were f o l l d during pregnancy, according to the plan: t r e a t m n t as e a r l y a s p o s s i b l e w i t h decadron 1 mg per day -transabdaninai chorion v i l l u s biopsy (at week 11) t o determine t h e sex -amniocentesis ( a t week 17) t o est a b l i s h (HIA t y p e s and s t e r o i d s ) i f the f e t u s is a f f e c t e d -continued treatnwt to b i r t h in a f f e c t e d girls. Case 1 (JIA) were treated f r a n 9 weeks o f pregnancy. The f e t u s turned o u t to be a boy, and trea-nt was stoppd. At b i r t h h e had n o s i g n s o f CAH ( n o r m 1 17 a -p r o g e s t e r o n e (1 7 OHP) , androstenedione (Adionel , t e s t o s t e r o n e , cortisol, A m , r e n i n ) .
Case 2 (FNO) was treated and s t u d i e d according t o the p l a n and the f e t u s was a g i r l , amniocentesis was p e r f o r m 4 and sh& raised v a l u e s f o r 17 OHP (30 m 1 / 1 ) , Adione (4 m l / l ) . She was HIAi d e n t i c a l to the a f f e c k d sister (A3B7/A3B47) and the treatment w i t h decadron (discontinued 5 days b e f o r e t h e amniocentesis) was Marginal s a l t l o s s and hyperreninemia were previously reported i n p a t i e n t s with 11-OHD on glucocorticoid replacement (JCEM 58:384, 1984) . To evaluate t h e need f o r mineralocortic o i d therapy, 7 p a t i e n t s with 11-OHD, 5-14 y e a r s of age, were subjected t o 3 consecutive schedules of treatment: 1) 1 mglday dexamethasone (DEX) f o r 4 days, 2) 17 mg/m2/day hydrocortisone a c e t a t e (HC) f o r 4 days, and 3 ) HC and 0.1-0.2 mg/day 9a-fluorohydrocortisone (9ctF) The l a t t e r combination suppressed PRA, produced b e t t e r control of t h e pituitary-adrenal a x i s and enabled t h e use of a physiol o g i c dose of HC. PRA needs t o be monitored in 1 I-OHD p a t i e n t s ; when i t i s elevated, mineralocorticoid replacement i s indicated.
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Fonctionnelles -H6pital Trousseau, P a r i s , France.
CONGENITAL VIRILIZING ADRENALI-IYPERPLASIA (CVAH) DUE TO 21 HYDROXYLASE DEFICIENCY, RESULTS OF THERAPY \VITH CYPROTERONE ACETATE (CA).
Results obtained from t e n prepubertal p a t i e n t s ( 6 g i r l s , 4 boys) s u f f e r i n g of CVAH were compared over 12-41 months periods before and over 14-52 months periods during CA therapy (63 f 21 (SD)mg/m2/day). A t t h e beginning of treatment with CA, growth parameters were a s follow : chronological (Ch) ages .03 ( p < .05) respectively. When compared t o normal values f o r B ages, most plasma DHA values were normal before (9110) and during (7/10), most A4 androstenedione (A4A) values were elevated before (9110) and normal (9110) during CA treatment, while A4A/T r a t i o s increased s i g n i f i c a n t l y from 3.7 ' .32 t o 6.4 .96 ( p < .01). I n conclusion, CA appears t o be of i n t e r e s t i n t h e treatment of prepubertal p a t i e n t s with CVAH. The antiandrogenic e f f e c t is dernonst r a t e d by t h e improvement of bone maturation, t h e i n h i b i t i o n of ACTH production by t h e decreases i n 170HP l e v e l s . In a d d i t i o n t h e r e is evidence of a decrease i n t h e conversion r a t e s of adrenal androgens t o testosterone. One of t h e goals of glucocorticoid therapy i n c l a ss i c a l CAH I s t o s u r e s s excess a w r o en roduction t o revent remature e p i e h y s e 8 c l o s u r e and resuytdn! s h o r t s t a r u r e . ~R i s r e t r o s p e c t i v e sttciy was conducted t o determine i f t h e f i n d l height (FH) of 45 a d u l t p a t i e n t s ( p t s ) with CAH was influenced by t h e c l i n i c a l v a r l a n t (salt-wasting (SW) vs simple v i r i l i z i n g (SV)), age diagnosis was made and treatment i n i t iated an3 t h e degree of hormonal control. Good o r poor hormonal cont;ol were determined f r a n l e v e l s of 24 hr urinary 17-KS, s e r 9 ~4 -a n d r o s t e n e d i one (~4 -A ) and 17-OHP. The p a t i e n t was asslgned t o t h e cdtegory of good c o~i t r o l i t n~ore than 50% of d a i l y urinary 17-KS o r serum ~4 -A wero normal f o r age (meank2SO o r i f 50% of t h e serum 17-OHP l e v e l s were < 1000 ng/dl. Ail others were assigned t o t h e poor control category; :i pts had i n s u f f i c i e n t d a t a f o r a s s i g m e n t . Final height was compared t o t h e mid-parental height (MPH t o t h e normal popul a t i o n , a~l l t o 5 never.trcated pts with h C A H The inlean f i n a l H t , f o r a l l male p a t i e n t s was 163.2 cm ark f o r a l l female p a t i e n t s was 153.3 cm. Conclusion: The a d u l t height of 3 never t r e a t e d females was not d l t t e r e n t from any t r e a t e d fe;,lales, whether i n yood o r poor control. S W o r SV, o r t r e a t e d e a r l y o r l a t e . Among t h e t r e a t e d males, height wa5 not d i f f e r e n t whether they were in good o r poor c o n t r o l , S W o r SV, o r t r e a t d e a r l y o r l a t e . Although t h e 2 never t r e a t e d males a r e s h o r t e r , t h a n t r e a t e d illales t h e small number of t s recludes statistical analysis. ~h 6 mean f i n a l heights 01 al! pts were s i n i f i c a n t l y l e s s than t h e mean heights of males and females i n t 4 e normal population.
